{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:31:56Z","timestamp":1794367916956,"version":"4.9.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Reprod Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jhrs.jhrs_133_19","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T03:27:46Z","timestamp":1603769266000},"page":"191","source":"Crossref","is-referenced-by-count":8,"title":["Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in In vitro fertilization"],"prefix":"10.4103","volume":"13","author":[{"given":"PuneetKaur","family":"Kochhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-1208.299237-1","first-page":"1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial.The European Orgalutran Study Group","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.299237-2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction","author":"Ludwig","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"key-10.4103\/0974-1208.299237-3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: Meta-analysis of fixed versus flexible protocol","author":"Al-Inany","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.299237-4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2010.05.052","article-title":"Fixed versus flexible gonadotropin-releasing hormone antagonist administration inin vitro fertilization: A randomized controlled trial","author":"Kolibianakis","year":"2011","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.299237-5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","article-title":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges inin vitro fertilization cycles","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.299237-6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2007.06.029","article-title":"Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: A randomized trial","author":"Lee","year":"2008","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.299237-7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/oxfordjournals.humrep.a138480","article-title":"Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis","author":"Hillier","year":"1994","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.299237-8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(00)01701-5","article-title":"A randomized prospective assessor-blind evaluation of luteinizing hormone dosage andin vitro fertilization outcome","author":"Gordon","year":"2001","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.299237-9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/dei386","article-title":"Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebocontrolled, multicentre trial","author":"Lambalk","year":"2006","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.299237-10","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/humrep\/deh357","article-title":"Dose-finding study of daily gonadotropinreleasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF\/ICSI patients: Antide and hormone levels","author":"Huirne","year":"2004","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.299237-11","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.fertnstert.2010.12.046","article-title":"In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle","author":"Kummer","year":"2011","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.299237-12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship within vitro fertilization outcome","author":"Bosch","year":"2003","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.299237-13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejogrb.2012.02.025","article-title":"The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist\/recombinant FSH-stimulated cycles","author":"Kyrou","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.4103\/0974-1208.299237-14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2174\/138920112799361927","article-title":"Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: A systematic review and meta-analysis","author":"Kolibianakis","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"key-10.4103\/0974-1208.299237-15","first-page":"3023","article-title":"The Ganirelix dose-finding study group","author":"A","year":"1998","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.299237-16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5653\/cerm.2013.40.2.90","article-title":"The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day inin vitro fertilization-embryo transfer cycles","author":"Choi","year":"2013","journal-title":"Clin Exp Reprod Med"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:53:04Z","timestamp":1786733584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_133_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["299237"],"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_133_19","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}